Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2517)
All Articles published online
|
Jan 28, 2006 (publication date) through Apr 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ji GZ, Wang XH, Miao L, Liu Z, Zhang P, Zhang FM, Yang JB. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma. World J Gastroenterol 2006; 12(4): 644-648 [PMID: 16489684 DOI: 10.3748/wjg.v12.i4.644] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i4/644.htm |
| Number | Citing Articles |
| 1 |
Ling Yang, Sayaka Inokuchi, Yoon Seok Roh, Jingyi Song, Rohit Loomba, Eek Joong Park, Ekihiro Seki. Transforming Growth Factor–β Signaling in Hepatocytes Promotes Hepatic Fibrosis and Carcinogenesis in Mice With Hepatocyte-Specific Deletion of TAK1. Gastroenterology 2013; 144(5): 1042 doi: 10.1053/j.gastro.2013.01.056
|
| 2 |
Wanglong Qiu, Chia-Yu Kuo, Yu Tian, Gloria H. Su. Dual Roles of the Activin Signaling Pathway in Pancreatic Cancer. Biomedicines 2021; 9(7): 821 doi: 10.3390/biomedicines9070821
|
| 3 |
Quanrongzi Wang, Tongfu Yu, Yifeng Yuan, Haiwen Zhuang, Zhaojing Wang, Xisheng Liu, Min Feng. Sorafenib reduces hepatic infiltrated regulatory T cells in hepatocellular carcinoma patients by suppressing TGF‐beta signal. Journal of Surgical Oncology 2013; 107(4): 422 doi: 10.1002/jso.23227
|
| 4 |
Haizhou Liu, Shaoyang Wang, Weimin Ma, Youguang Lu. Transforming Growth Factor β1 Promotes Migration and Invasion of Human Hepatocellular Carcinoma Cells Via Up-Regulation of Connective Tissue Growth Factor. Cell Biochemistry and Biophysics 2015; 73(3): 775 doi: 10.1007/s12013-015-0693-6
|
| 5 |
KAI SONG, JUNHUA WU, CHUNPING JIANG. Dysregulation of signaling pathways and putative biomarkers in liver cancer stem cells (Review). Oncology Reports 2013; 29(1): 3 doi: 10.3892/or.2012.2082
|
| 6 |
Ying Shi, Haipeng Zhang, Zhu Han, Xuguang Mi, Wenyan Zhang, Mingyu Lv. HBx interacted with Smad4 to deprive activin a growth inhibition function in hepatocyte HL7702 on CRM1 manner. Tumor Biology 2016; 37(3): 3405 doi: 10.1007/s13277-015-4076-9
|
| 7 |
SEN ZHANG, WU-YI SUN, JING-JING WU, YUAN-JING GU, WEI WEI. Decreased expression of the type III TGF-β receptor enhances metastasis and invasion in hepatocellullar carcinoma progression. Oncology Reports 2016; 35(4): 2373 doi: 10.3892/or.2016.4615
|
| 8 |
Olga Kalinina, Agnès Marchio, Aleksandr I. Urbanskii, Aleksandra B. Tarkova, Khadija Rebbani, Dmitri A. Granov, Anne Dejean, Mikhail I. Generalov, Pascal Pineau. Somatic changes in primary liver cancer in Russia: A pilot study. Mutation Research/Genetic Toxicology and Environmental Mutagenesis 2013; 755(2): 90 doi: 10.1016/j.mrgentox.2013.06.019
|
| 9 |
Hui Peng, Satoru Shintanit, Yong Kim, David T. Wong. Loss of p12CDK2-AP1 Expression in Human Oral Squamous Cell Carcinoma with Disrupted Transforming Growth Factor-β-Smad Signaling Pathway. Neoplasia 2006; 8(12): 1028 doi: 10.1593/neo.06580
|
| 10 |
Argyro Voumvouraki, George Notas, Mairi Koulentaki, Maria Georgiadou, Stefanos Klironomos, Elias Kouroumalis. Increased serum activin‐A differentiates alcoholic from cirrhosis of other aetiologies. European Journal of Clinical Investigation 2012; 42(8): 815 doi: 10.1111/j.1365-2362.2012.02647.x
|
| 11 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2017; : 3007 doi: 10.1007/978-3-319-26956-6_167
|
| 12 |
Alev Deli, Emanuel Kreidl, Stefan Santifaller, Barbara Trotter, Katja Seir, Walter Berger, Rolf Schulte-Hermann, Chantal Rodgarkia-Dara, Michael Grusch. Activins and activin antagonists in hepatocellular carcinoma. World Journal of Gastroenterology 2008; 14(11): 1699-1709 doi: 10.3748/wjg.14.1699
|
| 13 |
Wen Cao, Chao Hu, Lingling Wu, Liba Xu, Weizhe Jiang. Rosmarinic acid inhibits inflammation and angiogenesis of hepatocellular carcinoma by suppression of NF-κB signaling in H22 tumor-bearing mice. Journal of Pharmacological Sciences 2016; 132(2): 131 doi: 10.1016/j.jphs.2016.09.003
|
| 14 |
Lei Yao, Fu-Jun Li, Zhi-Qiang Tang, Shuang Gao, Qe-Quan Wu. Smad4 Expression in Hepatocellular Carcinoma Differs by Hepatitis Status. Asian Pacific Journal of Cancer Prevention 2012; 13(4): 1297 doi: 10.7314/APJCP.2012.13.4.1297
|
| 15 |
Arthur Zimmermann. Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. 2016; : 1 doi: 10.1007/978-3-319-26587-2_167-1
|